Established in 2019, MiyaHealth is currently offering two tech products. One is MiyaPatient, a patient navigation platform that is built with a predictive and personalized system to help users manage their chronic illness. Another is MiyaPayor, a platform that combines AI-driven claims processing and predictive analytics and assists insurers and corporates in designing health plans and bringing down administrative and medical costs in healthcare. MiyaHealth, a health tech startup from Singapore, has scored SG$6.5 million ($4.8 million) in a pre-Series A funding round led by Singapore Technologies Engineering Ventures, the venture capital arm of listed engineering group ST Engineering, and deep tech investor Elev8. This brings its total investments raised to over SG$9 million ($6.6 million).
MiyaHealth will deploy its fresh funds for product development and expansion. Specifically, it will be used to introduce MiyaPayor in Indonesia and launch MiyaProvider in Malaysia by the second quarter. It also plans to bring MiyaPatient for the first time to Europe. To accompany its buildout, the company is recruiting more staff in its offices in Singapore, Kuala Lumpur, and Jakarta.